NEW YORK (GenomeWeb News) – Nanotechnology firm NanoInk today said that it has launched a new division called NanoBioDiscovery that will focus on supplying technologies for biomarker research and drug discovery.
 
The Skokie, Ill.-based firm said that the new division will use its Dip Pen Nanolithography nanofabrication techniques and detection systems to produce assays for protein discovery and identification. It believes its technology can provide researchers with enhanced reaction kinetics and assay cost savings.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Hundreds of scientists have signed a letter criticizing the open-access Plan S, ScienceInsider reports.

NPR speaks with Rep. Eddie Bernice Johnson (D-Texas) about the US House of Representatives science committee.

A start-up company aiming to match cancer patients to treatments closes after about six weeks, Stat News reports.

In PLOS this week: somatic mutation associations unearthed in thousands of cancer exomes, pathogen detection assay, and more.